National Presenting Sponsors

Survivorship and Hope

BeOne Medicines (formerly BeiGene) is proud to support the Leukemia & Lymphoma Society as the National Sponsor of Survivorship and Hope for Light The Night events across the U.S. As a global oncology company committed to developing and delivering innovative medicines, putting patients first is a core value and drives everything we do. To learn more about our commitment to the blood cancer community, visit beonemedicines.us.

Leading Lights

AbbVie is honored to be a continuous sponsor of The Leukemia & Lymphoma Society for more than a decade including Light The Night in support of the LLS’ efforts to help patients before, during and after their blood cancer diagnosis and treatment.

AbbVie is committed to advancing medicines and science in oncology to help treat patients with difficult-to-treat cancers and deliver a meaningful impact on patients’ lives.

For more information, please visit AbbVie.com

Fundraising Heros

Builders FirstSource cares about our people and the communities we serve. From our safety-first company culture to our involvement in charities and sustainable building, we’re committed to the greater good. Giving back is built into who we are, and nothing demonstrates that better than the longstanding partnership between Builders FirstSource and The Leukemia & Lymphoma Society. Over the past 18 years, we’ve raised more than $13 million for LLS and thousands of our team members have participated in Light The Night events across the nation. Together, we are working to build a future without blood cancer. Visit www.bldr.com to learn more.

Luminary

Amgen is proud to be a National Sponsor of Light The Night, a nationwide fundraising campaign of The Leukemia & Lymphoma Society.

Across the United States, Amgen employees will form teams to raise funds and disease awareness for blood cancers by joining Light The Night events in their communities.

In everything we do, we aim to fulfill our mission to serve patients. Participating in The Leukemia & Lymphoma Society’s Light The Night demonstrates this promise. We invite you to learn more about Amgen at Amgen.com.

For the eighth year in a row, AstraZeneca is proud to be a national sponsor of the Leukemia & Lymphoma Society’s Light The Night. We recognize that cancer’s impact extends beyond the patient, affecting caregivers and loved ones too. It’s through collaboration with the blood cancer community that we can drive innovative research and transform care for everyone touched by this disease. To learn more about AstraZeneca’s dedication in the fight against cancer, please visit www.astrazeneca-us.com and follow us on LinkedIn (@AstraZeneca), Instagram (@AstraZenecaUS), Facebook (@AstraZenecaUSCommunityConnections).

Bristol Myers Squibb is committed to our strong partnership with The Leukemia & Lymphoma Society (LLS) through Light The Night. The mission of LLS is tied to Bristol Myers Squibb’s vision of transforming patients’ lives through science, making it an important and worthy initiative that we are proud to support. Our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Learn more about Bristol Myers Squibb’s commitment to patients at BMS.com.

At Daiichi Sankyo, we create essential medicine for longer, better lives. Every day, we strive to put our skills at the service of those most in need. By uniting cutting-edge science and technology with a genuine interest in people, we develop high-quality, life-changing solutions for the patients of today and tomorrow with great care and unwavering dedication. We rely on reason, ingenuity, perseverance and empathy to make bold strides in oncology.

Building on a 120-year heritage and a culture of innovation, we’re forging better futures through medicine for people everywhere. Together, we are creating new standards of care—our contribution to the enrichment of quality of life around the world. Please visit www.daiichisankyo.us.

Genentech is a proud National Sponsors of The Leukemia & Lymphoma Society's (LLS) Light The Night Walk. Genentech is committed to meeting the needs of cancer patients, their families, caregivers and healthcare professionals.

Along with their Light The Night involvement, Genentech has been supporting LLS's national patient education and outreach programs for more than ten years. Our support is focused in the areas of lymphoma education, patient navigation and access to care.

To learn more visit www.gene.com.

Gilead and Kite Oncology are creating the future of oncology. From antibody-drug conjugates and small molecules to cell therapy, our research and development programs and partnerships are creating possibilities for people with overlooked, underserved and difficult-to-treat cancers. We are focused on helping to bring more life to people with cancer and changing the way cancer is treated. We are a proud national partner of Light the Night. Each year we raise awareness and funds for The Leukemia & Lymphoma Society by participating in Light The Night walks across the country. Our partnership began with the LLS Therapy Acceleration Program and has expanded to include educational programs and charitable opportunities to support blood cancer patients in their time of need. Visit Gilead.com and KitePharma.com to learn more.

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn.

Novartis is honored to support The Leukemia & Lymphoma Society’s Light the Night as a national sponsor. We are proud to stand alongside the blood cancer community and remain committed to reimagining medicine to improve and extend people’s lives. Together, we aim to offer support and resources to patients and their caregivers in the blood cancer community. To learn more about Novartis, please visit www.Novartis.com.

2025 marks the 10th year Pfizer has been a national sponsor of Light The Night and we couldn’t be prouder to support this cause. Pfizer is committed to helping with the complex challenges faced by people living with blood cancer, but we know we can’t do this alone. Together with our partners, like LLS, we offer resources to help people with blood cancer and their caregivers in their journey fighting cancer, as we aim to improve lives and provide hope for the future. Visit Let’s Outdo Cancer: Pfizer’s Commitment to Taking on Cancer to learn more.”

At Syndax, our passion for patients underpins all that we do, and to that end, we are honored to support the Leukemia & Lymphoma Society’s Light the Night as a national sponsor. For the last eight years, we have joined hands with patients, their families, caregivers and survivors to shine a light on the importance of finding cures for cancer through our sponsorship of this event and beyond. With our shared mission to improve the lives of patients with cancer, we are proud of our enduring partnership with LLS.

We invite you to learn more about our unwavering dedication to patients by visiting www.syndax.com or follow the Company on X and LinkedIn.